Top Midday Decliners

MT Newswires Live05-29

InflaRx (IFRX) shares sank 60% after the company said Wednesday it plans to discontinue development of vilobelimab in pyoderma gangrenosum, a rare and inflammatory skin disease.

More than 5.48 million shares traded intraday, compared with a daily average of about 301,000.

Cemtrex (CETX) said it priced a firm commitment underwritten public offering of 1.25 million shares at $1.00 apiece.

Shares slumped 46%, with intraday trading volume of over 2.56 million against a daily average of about 299,000.

Exodus Movement (EXOD) filed a registration statement late Tuesday for the sale of up to $1 billion of securities, including class A stock and debt, from time to time.

Shares dropped 21% as intraday trading volume rose to more than 220,000 from a daily average of roughly 96,000.

Price: 0.73, Change: -1.09, Percent Change: -59.89

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2539405824?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-29 02:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2539405824","market":"fut","top_or_hot":-1,"title":"Top Midday Decliners","media":"MT Newswires Live","content":"<html><body><p> InflaRx (IFRX) shares sank 60% after the company said Wednesday it plans to discontinue development of vilobelimab in pyoderma gangrenosum, a rare and inflammatory skin disease.</p><p>More than 5.48 million shares traded intraday, compared with a daily average of about 301,000.</p><p>Cemtrex (CETX) said it priced a firm commitment underwritten public offering of 1.25 million shares at $1.00 apiece.</p><p>Shares slumped 46%, with intraday trading volume of over 2.56 million against a daily average of about 299,000.</p><p>Exodus Movement (EXOD) filed a registration statement late Tuesday for the sale of up to $1 billion of securities, including class A stock and debt, from time to time.</p><p>Shares dropped 21% as intraday trading volume rose to more than 220,000 from a daily average of roughly 96,000.</p><p>Price: 0.73, Change: -1.09, Percent Change: -59.89</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Decliners</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Decliners\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-05-29 02:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> InflaRx (IFRX) shares sank 60% after the company said Wednesday it plans to discontinue development of vilobelimab in pyoderma gangrenosum, a rare and inflammatory skin disease.</p><p>More than 5.48 million shares traded intraday, compared with a daily average of about 301,000.</p><p>Cemtrex (CETX) said it priced a firm commitment underwritten public offering of 1.25 million shares at $1.00 apiece.</p><p>Shares slumped 46%, with intraday trading volume of over 2.56 million against a daily average of about 299,000.</p><p>Exodus Movement (EXOD) filed a registration statement late Tuesday for the sale of up to $1 billion of securities, including class A stock and debt, from time to time.</p><p>Shares dropped 21% as intraday trading volume rose to more than 220,000 from a daily average of roughly 96,000.</p><p>Price: 0.73, Change: -1.09, Percent Change: -59.89</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EXOD","symbol_name":"Exodus Movement, Inc.","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2539405824","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2539405824","pubTimestamp":1748456229,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"InflaRx  shares sank 60% after the company said Wednesday it plans to discontinue development of vilobelimab in pyoderma gangrenosum, a rare and inflammatory skin disease.More than 5.48 million shares traded intraday, compared with a daily average of about 301,000.Cemtrex  said it priced a firm commitment underwritten public offering of 1.25 million shares at $1.00 apiece.Shares slumped 46%, with intraday trading volume of over 2.56 million against a daily average of about 299,000.Exodus Movement  filed a registration statement late Tuesday for the sale of up to $1 billion of securities, including class A stock and debt, from time to time.Shares dropped 21% as intraday trading volume rose to more than 220,000 from a daily average of roughly 96,000.Price: 0.73, Change: -1.09, Percent Change: -59.89","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"EXOD":"Exodus Movement, Inc.","BK4139":"生物科技","CETX":"Cemtrex Inc.","IFRX":"InflaRx N.V.","BK4145":"电子制造服务","BK4023":"应用软件","BK4157":"电子设备和仪器"},"translate_title":"午盘跌幅最大的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CETX":0.9,"IFRX":0.9,"EXOD":0.9},"content_text":"InflaRx (IFRX) shares sank 60% after the company said Wednesday it plans to discontinue development of vilobelimab in pyoderma gangrenosum, a rare and inflammatory skin disease.More than 5.48 million shares traded intraday, compared with a daily average of about 301,000.Cemtrex (CETX) said it priced a firm commitment underwritten public offering of 1.25 million shares at $1.00 apiece.Shares slumped 46%, with intraday trading volume of over 2.56 million against a daily average of about 299,000.Exodus Movement (EXOD) filed a registration statement late Tuesday for the sale of up to $1 billion of securities, including class A stock and debt, from time to time.Shares dropped 21% as intraday trading volume rose to more than 220,000 from a daily average of roughly 96,000.Price: 0.73, Change: -1.09, Percent Change: -59.89","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2539405824","isCrawlerRequest":true}